These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 18432323)
41. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases]. Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111 [No Abstract] [Full Text] [Related]
42. High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease. Conti V; Leone MC; Casato M; Nicoli M; Granata G; Carlesimo M Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):54-7. PubMed ID: 25781195 [TBL] [Abstract][Full Text] [Related]
43. Disease evolution and organ damage accrual in patients with stable UCTD: a long-term monocentric inception cohort. Tani C; Trentin F; Parma A; Zucchi D; Cardelli C; Stagnaro C; Elefante E; Signorini V; Carli L; Manca ML; Mosca M RMD Open; 2024 Apr; 10(2):. PubMed ID: 38670557 [TBL] [Abstract][Full Text] [Related]
44. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Mosca M; Tani C; Bombardieri S Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1011-23. PubMed ID: 18068858 [TBL] [Abstract][Full Text] [Related]
45. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Mosca M; Neri R; Bombardieri S Clin Exp Rheumatol; 1999; 17(5):615-20. PubMed ID: 10544849 [TBL] [Abstract][Full Text] [Related]
46. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic. Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885 [TBL] [Abstract][Full Text] [Related]
47. UCTD and SLE patients show increased levels of oxidative and DNA damage together with an altered kinetics of DSB repair. Micheli C; Parma A; Tani C; Di Bello D; Falaschi A; Chiaramonte A; Testi S; Mosca M; Scarpato R Mutagenesis; 2021 Nov; 36(6):429-436. PubMed ID: 34559237 [TBL] [Abstract][Full Text] [Related]
48. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ghirardello A; Doria A; Zampieri S; Gerli R; Rapizzi E; Gambari PF Ann Rheum Dis; 2000 Dec; 59(12):975-81. PubMed ID: 11087701 [TBL] [Abstract][Full Text] [Related]
49. Applying SLICC and ACR/EULAR systemic lupus erythematosus classification criteria in a cohort of patients with undifferentiated connective tissue disease. Drehmel KR; Erickson AR; England BR; Michaud KD; Sayles HR; Hearth-Holmes MP Lupus; 2021 Feb; 30(2):280-284. PubMed ID: 33252299 [TBL] [Abstract][Full Text] [Related]
50. The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Ohtsuka T; Tamura T; Yamakage A; Yamazaki S Br J Dermatol; 1998 Oct; 139(4):622-9. PubMed ID: 9892906 [TBL] [Abstract][Full Text] [Related]
51. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [TBL] [Abstract][Full Text] [Related]
52. [Undifferentiated connective tissue disease : what is it ?]. Brulhart L Rev Med Suisse; 2021 Mar; 17(729):498-500. PubMed ID: 33689247 [TBL] [Abstract][Full Text] [Related]
53. Intracranial lesion as onset symptom in a patient with early undifferentiated connective tissue disease: a case report. Du Y; Li C; Zhao DD; Lu JR; Zhang W; Li ZY BMC Neurol; 2017 May; 17(1):85. PubMed ID: 28476103 [TBL] [Abstract][Full Text] [Related]
54. [Sharp's syndrome. Clinical, immunological and nosographic aspects]. Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325 [TBL] [Abstract][Full Text] [Related]
55. Undifferentiated connective tissue disease: state of the art on clinical practice guidelines. Antunes M; Scirè CA; Talarico R; Alexander T; Avcin T; Belocchi C; Doria A; Franceschini F; Galetti I; Govoni M; Hachulla E; Launay D; Lepri G; Macieira C; Matucci-Cerinic M; Montecucco CM; Moraes-Fontes MF; Mouthon L; Paolino S; Ramoni V; Tani C; Tas SW; Tincani A; Van Vollenhoven R; Zen M; Fonseca J; Bombardieri S; Fonseca JE; Schneider M; Smith V; Cutolo M; Mosca M; Beretta L RMD Open; 2018; 4(Suppl 1):e000786. PubMed ID: 30886731 [TBL] [Abstract][Full Text] [Related]
56. Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review. Nakken B; Bodolay E; Szodoray P Clin Rev Allergy Immunol; 2015 Oct; 49(2):152-62. PubMed ID: 25274451 [TBL] [Abstract][Full Text] [Related]
57. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China. Zhao J; Wang Q; Liu Y; Tian Z; Guo X; Wang H; Lai J; Huang C; Yang X; Li M; Zeng X Int J Cardiol; 2017 Jun; 236():432-437. PubMed ID: 28159359 [TBL] [Abstract][Full Text] [Related]